October 7, 2024
TB Alliance Awarded $7.35 Million by U.S. Department of Defense for Novel Tuberculosis Interventions
September 3, 2024
Brazil and Philippines Accelerate Availability of Shorter Drug-Resistant Tuberculosis Treatment
Brazil’s TB Program Works with Manila’s PeerLINC Knowledge Hub to Roll Out New TB Regimen August 21, 2024
New Clinical Trial Examines Use of Novel Compound Telacebec in Buruli Ulcer Patients
Global Leader in TB Drug Development Expands Efforts to Tackle Other Neglected Diseases August 15, 2024
Ann E. Taylor, MD Joins the TB Alliance Board of Directors
March 25, 2024
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants March 25, 2024
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures January 31, 2024